Clinical Trials
23 trialsNCT04519476 2023-10-31
Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy.
Oncotherapeutics
Phase 1 Unknown
NCT05855395 2023-07-12
The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19
Huashan Hospital
Phase NA Unknown
NCT04810156 2022-12-14
I-HEP
Herlev Hospital
Phase 2 Unknown
NCT05280873 2022-03-15
Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP
Guangzhou Institute of Respiratory Disease
Phase 1 Unknown
NCT02944045 2020-10-06
PIC
Assistance Publique - Hôpitaux de Paris
Phase 3 Unknown
NCT03390387 2020-02-05
ALL-MB 2015
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase NA Unknown
NCT02060656 2019-09-19
LEGEND
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT02344888 2019-01-08
Adding Prednisolone During Ovulation Induction With CC in Lean Women With CC Resistant PCOS
Mansoura University
Phase 4 Unknown
NCT01719835 2018-03-15
CHEMO-T
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT02912702 2016-09-23
L-DEP as an Initial Treatment for EBV-HLH
Beijing Friendship Hospital
Phase 3 Unknown
NCT02631109 2016-08-04
L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis
Beijing Friendship Hospital
Phase 3 Unknown
NCT02304094 2016-03-29
Morton's Neuroma: Manipulation Versus Steroid Injection
Queen Margaret University
Phase NA Unknown
NCT01884428 2014-01-29
Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma
Istituto Clinico Humanitas
Phase 1 Unknown
NCT00084695 2014-01-10
Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01005758 2014-01-10
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00008307 2014-01-06
Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00002599 2013-12-19
Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00436761 2013-12-18
Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors
National Cancer Institute (NCI)
Phase 1 Unknown
NCT01670812 2012-08-22
Trial of FFP+HDMP+Rituximab for Ultra-high Risk Chronic Lymphocytic Leukemia
The First Affiliated Hospital with Nanjing Medical University
Phase 3 Unknown
NCT00003728 2011-01-21
Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00053105 2009-07-07
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00069966 2009-07-07
Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00903188 2009-05-18
CISTCERT
University Hospital, Antwerp
Phase 4 Unknown